Trubion Pharmaceuticals Inc.

88 articles with Trubion Pharmaceuticals Inc.

• Trubion Pharmaceuticals Inc. Announces Appointment of New Chief Medical Officer

  8/19/2008

• Trubion Pharmaceuticals Inc. Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference Call

  8/1/2008

• Trubion Pharmaceuticals Inc. Announces Extension of Research Period Under Its Wyeth Collaboration

  6/20/2008

• Trubion Pharmaceuticals Inc. Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting

  6/17/2008

• Trubion Pharmaceuticals Inc. to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference

  6/5/2008

• Trubion Pharmaceuticals Inc. Announces Presentation of Positive TRU-016 Data at American Society of Clinical Oncology TRU-016 Produces Significant Anti-Tumor Activity and Long-Term Tumor Regression in Pre-Clinical Studies

  6/3/2008

• Trubion Pharmaceuticals Inc. Reports First Quarter 2008 Results

  5/9/2008

• Trubion Pharmaceuticals Inc. Provides Announcement Dates for First-Quarter Earnings Conference Call

  5/2/2008

• Trubion Pharmaceuticals Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis

  4/22/2008

• Trubion Pharmaceuticals Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis

  4/22/2008

• Trubion Pharmaceuticals Inc. Initiates Phase 1/2 Study of TRU-016 in CLL

  3/28/2008

• Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook

  3/14/2008

• Trubion Pharmaceuticals Inc. Announces Presentations at Upcoming Investor Conferences

  3/7/2008

• Trubion Pharmaceuticals Inc. Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call

  3/7/2008

• Trubion Pharmaceuticals Inc. Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma

  12/11/2007

• Trubion Pharmaceuticals Inc. Announces Upcoming Presentation at the 2007 American Society of Hematology Annual Meeting

  12/7/2007

• Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results

  11/13/2007

• Trubion Pharmaceuticals Inc. Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis

  11/9/2007

• Trubion Pharmaceuticals Inc. Provides Announcement Dates for Third-Quarter Earnings

  11/6/2007

• Trubion Pharmaceuticals Inc. Shares Plunge After Arthritis Trial Results

  9/11/2007